PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1568702
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1568702
U.S. Home Infusion Therapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
The U.S. home infusion therapy market size is expected to grow at a 10.1% CAGR from 2024 to 2032 led by rising preference for home-based healthcare services.
As the healthcare landscape pivots towards patient-centric models, home infusion therapy emerges as a convenient and cost-effective alternative to traditional hospital treatments. This transition is bolstered by an aging population grappling with chronic conditions like diabetes, cancer, and heart disease, all of which necessitate long-term infusion therapy and amplify the demand for home-based solutions.
Increased payer support and expanded reimbursement options for home infusion services broaden accessibility, easing financial hurdles for patients. The rise of specialized home infusion pharmacies, alongside innovative infusion devices and technologies, further boosts the efficiency and safety of home therapies.
The overall industry is divided into product, application, and zone.
Based on product, the U.S. home infusion therapy market size from the needleless connectors segment is slated to witness a robust growth rate from 2024-2032. This is due to their enhanced safety and ease of use, which are crucial for home-based treatments. Needleless connectors reduce the risk of needle-stick injuries and infections, improving safety for both patients and caregivers.
U.S. home infusion therapy market value from the enteral nutrition application segment is poised to depict a significant CAGR from 2024 to 2032. This is owing to the increasing prevalence of chronic diseases and conditions that impair normal eating, such as gastrointestinal disorders, neurological conditions, and cancer. Enteral nutrition provides a vital alternative for patients who cannot consume food orally, offering a convenient and effective way to deliver essential nutrients directly to the digestive system at home.
U.S. Pacific Central home infusion therapy industry is projected to depict sustained growth from 2024-2032 attributed to the increasing healthcare infrastructure investments and the rising demand for patient-centered care. The adoption of advanced home infusion technologies, coupled with supportive healthcare policies and reimbursement frameworks, facilitates the delivery of complex therapies in home settings in the region.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing hospital acquired infections
- 3.2.1.2 Rising prevalence of chronic diseases
- 3.2.1.3 Advancements in technology
- 3.2.1.4 Growing geriatric population
- 3.2.1.5 Increasing preference towards at-home healthcare solutions
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Safety concerns and risk of failure associated with home infusion devices
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 List of hospitals/clinics referring home infusion therapy
- 3.6 Number of home infusion therapy patients 2021 - 2023
- 3.7 Reimbursement scenario
- 3.8 Gap analysis
- 3.9 Porter's analysis
- 3.10 PESTEL analysis
- 3.11 Future market trends
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Infusion pumps
- 5.3 Intravenous sets
- 5.4 IV cannulas
- 5.5 Needleless connectors
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Anti-infectives
- 6.3 Hydration therapy
- 6.4 Chemotherapy
- 6.5 Enteral nutrition
- 6.6 Parenteral nutrition
- 6.7 Specialty pharmaceuticals
- 6.8 Other applications
Chapter 7 Market Estimates and Forecast, By Zone, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 East North central
- 7.2.1 Illinois
- 7.2.2 Indiana
- 7.2.3 Michigan
- 7.2.4 Ohio
- 7.2.5 Wisconsin
- 7.3 West South central
- 7.3.1 Arkansas
- 7.3.2 Louisiana
- 7.3.3 Oklahoma
- 7.3.4 Texas
- 7.4 South Atlantic
- 7.4.1 Delaware
- 7.4.2 Florida
- 7.4.3 Georgia
- 7.4.4 Maryland
- 7.4.5 North carolina
- 7.4.6 South carolina
- 7.4.7 Virginia
- 7.4.8 West Virginia
- 7.4.9 Washington, D.C.
- 7.5 Northeast
- 7.5.1 Connecticut
- 7.5.2 Maine
- 7.5.3 Massachusetts
- 7.5.4 New hampshire
- 7.5.5 Rhode Island
- 7.5.6 Vermont
- 7.5.7 New Jersey
- 7.5.8 New York
- 7.5.9 Pennsylvania
- 7.6 East South Central
- 7.6.1 Alabama
- 7.6.2 Kentucky
- 7.6.3 Mississippi
- 7.6.4 Tennessee
- 7.7 West North Central
- 7.7.1 Iowa
- 7.7.2 Kansas
- 7.7.3 Minnesota
- 7.7.4 Missouri
- 7.7.5 Nebraska
- 7.7.6 North Dakota
- 7.7.7 South Dakota
- 7.8 Pacific Central
- 7.8.1 Alaska
- 7.8.2 California
- 7.8.3 Hawaii
- 7.8.4 Oregon
- 7.8.5 Washington
- 7.9 Mountain States
- 7.9.1 Arizona
- 7.9.2 Colorado
- 7.9.3 Utah
- 7.9.4 Nevada
- 7.9.5 New Mexico
- 7.9.6 Idaho
- 7.9.7 Montana
- 7.9.8 Wyoming
Chapter 8 Company Profiles
- 8.1 AMERITA INC.
- 8.2 Amsino International, Inc.
- 8.3 B. Braun Melsungen AG
- 8.4 Baxter International Inc.
- 8.5 Becton, Dickinson and Company
- 8.6 Contec Medical Systems Co. Ltd
- 8.7 Erenler Medikal
- 8.8 Fresenius Kabi AG
- 8.9 Halyard Health, Inc. (Avanos Medical)
- 8.10 ICU Medical Inc.
- 8.11 JMS Co. Ltd.
- 8.12 Lepu Medical Technology
- 8.13 Moog Inc.
- 8.14 Option Care Health, Inc.
- 8.15 Terumo Corporation
